{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:11:16Z","timestamp":1762521076403,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.conctc.2021.100743","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T14:41:22Z","timestamp":1613572882000},"page":"100743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Comparison of the outcomes of the prolonged antianginal therapy use in stable coronary artery disease patients according to the data of randomized and observational studies"],"prefix":"10.1016","volume":"21","author":[{"given":"S.Yu.","family":"Martsevich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu.V.","family":"Lukina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.P.","family":"Kutishenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3033-3450","authenticated-orcid":false,"given":"Yu.V.","family":"Semenova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.conctc.2021.100743_bib1","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N. Engl. J. Med."},{"author":"Hochman","key":"10.1016\/j.conctc.2021.100743_bib2"},{"issue":"38","key":"10.1016\/j.conctc.2021.100743_bib3","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. 2013 ESC guidelines on the management of stable coronary artery disease","volume":"34","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.conctc.2021.100743_bib4","article-title":"Effect of nicorandil on coronary events in patients with stable angina: the Impact of Nicorandil in Angina (IONA): randomized trial","volume":"35","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.conctc.2021.100743_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40801-019-0156-2","article-title":"Re-evaluating safety and effectiveness of dabigatran versus warfarin in a nationwide data environment: a prevalent new-user design study","volume":"6","author":"Lin","year":"2019","journal-title":"Drugs Real World Outcomes"},{"issue":"7","key":"10.1016\/j.conctc.2021.100743_bib6","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00125-014-3263-3","article-title":"The efficacy and effectiveness of drugs for diabetes: how do clinical trials and the real world compare?","volume":"57","author":"Pratley","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.conctc.2021.100743_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s13063-015-1023-4","article-title":"A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results","volume":"16","author":"Kennedy-Martin","year":"2015","journal-title":"Trials"},{"key":"10.1016\/j.conctc.2021.100743_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2019.1501","article-title":"Representativeness of randomized clinical trial cohorts in end-stage kidney disease: a meta-analysis","author":"Smyth","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.conctc.2021.100743_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/thx.2006.066837","article-title":"External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?","volume":"62","author":"Travers","year":"2007","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.conctc.2021.100743_bib10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4082\/kjfm.2013.34.4.227","article-title":"Efficacy versus effectiveness","volume":"34","author":"Kim","year":"2013","journal-title":"Korean J Fam Med"},{"issue":"9","key":"10.1016\/j.conctc.2021.100743_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.15829\/1560-4071-2017-9-75-82","article-title":"Observational multicenter trial of nicorandil use in stable coronary heart disease high-risk patients (NIKEA): design and first results","author":"Martsevich","year":"2017","journal-title":"Russian J. Cardiol."},{"issue":"2","key":"10.1016\/j.conctc.2021.100743_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1345\/aph.1D252","article-title":"Measurement, correlates, and Health outcomes of medication adherence among seniors","volume":"38","author":"Vik","year":"2004","journal-title":"Ann. Pharmacother."},{"issue":"21","key":"10.1016\/j.conctc.2021.100743_bib14","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1001\/jama.1993.03500210079036","article-title":"Is this patient taking the treatment as prescribed?","volume":"269","author":"Stephenson","year":"1993","journal-title":"J. Am. Med. Assoc.: JAMA, J. Am. Med. Assoc."},{"issue":"6","key":"10.1016\/j.conctc.2021.100743_bib12","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1136\/heart.85.6.e9","article-title":"Trial to show the impact of nicorandil in angina (IONA): design, methodology, and management","volume":"85","year":"2001","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.conctc.2021.100743_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pupt.2014.01.005","article-title":"Randomized Controlled Trials and real life studies. Approaches and methodologies: a clinical point of view","volume":"27","author":"Saturni","year":"2014","journal-title":"Pulm. Pharmacol. Therapeut."},{"issue":"10","key":"10.1016\/j.conctc.2021.100743_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110403","article-title":"Results of observational studies: analysis of findings from the Nurses' Health Study","volume":"9","author":"Tai","year":"2014","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.conctc.2021.100743_bib17","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jjcc.2016.08.010","article-title":"Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation","volume":"69","author":"Bengtson","year":"2017","journal-title":"J. Cardiol."}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865421000454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865421000454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:03:41Z","timestamp":1762520621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865421000454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":17,"alternative-id":["S2451865421000454"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2021.100743","relation":{},"ISSN":["2451-8654"],"issn-type":[{"type":"print","value":"2451-8654"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the outcomes of the prolonged antianginal therapy use in stable coronary artery disease patients according to the data of randomized and observational studies","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2021.100743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100743"}}